Could Proteomic Research Deliver the Next Generation of Treatments for Pneumococcal Meningitis?

Goonetilleke, U, Ward, Stephen ORCID: https://orcid.org/0000-0003-2331-3192 and Gordon, Stephen ORCID: https://orcid.org/0000-0001-6576-1116 (2009) 'Could Proteomic Research Deliver the Next Generation of Treatments for Pneumococcal Meningitis?'. Interdisciplinary Perspectives on Infectious Diseases, Vol 2009, Article ID 214216.

Preview

Text Could_porteomic_research_deliver_the_next_generation_of_treaments_for_pneumococcal_meningitis.pdf - Published Version Available under License Creative Commons Attribution Non-commercial. Download (1MB)

Abstract

Streptococcus pneumoniae is the most common bacterial cause of community-acquired meningitis worldwide. Despite optimal antibiotic therapy and supportive care, the mortality of this condition remains very high at 20–30% in the developed world and over 60% in under-resourced hospitals. In developed countries, approximately half of the survivors suffer intellectual impairment, hearing loss, or other neurological damage. There is an urgent need for more information about the mechanisms of brain damage and death in pneumococcal meningitis so that new treatments can be designed. Using proteomic techniques and bioinformatics, the protein content of cerebrospinal fluid can be examined in great detail. Animal models have added greatly to our knowledge of possible mechanisms and shown that hippocampal apoptosis and cortical necrosis are distinct mechanisms of neuronal death. The contribution of these pathways to human disease is unknown. Using proteomic techniques, neuronal death pathways could be described in CSF samples. This information could lead to the design of novel therapies to minimize brain damage and lower mortality. This minireview will summarize the known pathogenesis of meningitis, and current gaps in knowledge, that could be filled by proteomic analysis.

Item Type:	Article
Subjects:	QU Biochemistry > Proteins. Amino Acids. Peptides > QU 58.5 DNA. WB Practice of Medicine > Therapeutics > WB 330 Drug therapy WC Communicable Diseases > WC 20 Research (General) WC Communicable Diseases > Infection. Bacterial Infections > Bacterial Infections > WC 210 Streptococcal infections (General or not elsewhere classified) WC Communicable Diseases > Infection. Bacterial Infections > Bacterial Infections > WC 217 Pneumococcal infections
Faculty: Department:	Groups (2002 - 2012) > Clinical Group
Digital Object Identifer (DOI):	https://doi.org/10.1155/2009/214216
Depositing User:	Users 379 not found.
Date Deposited:	27 Sep 2012 09:40
Last Modified:	07 Oct 2019 08:23
URI:	https://archive.lstmed.ac.uk/id/eprint/3045

Statistics

View details

Actions (login required)

Edit Item